{"id":89485,"date":"2023-03-03T11:30:00","date_gmt":"2023-03-03T10:30:00","guid":{"rendered":"https:\/\/cms.munich-startup.net\/?p=89485"},"modified":"2023-03-02T15:18:45","modified_gmt":"2023-03-02T14:18:45","slug":"visionhealth-pre-series-a-financing","status":"publish","type":"post","link":"https:\/\/cms.munich-startup.net\/en\/89485\/visionhealth-pre-series-a-financing\/","title":{"rendered":"3 million euros for Visionhealth"},"content":{"rendered":"<div class=\"entry-content\">\n<p>In a pre-Series A financing round, Visionhealth secured three million euros from DB Speciality Invest GmbH &amp; Co. KG. The owner of this investment company is life science entrepreneur Dietrich Bruchmann, founder and managing director of <a href=\"https:\/\/www.nuvisan.de\/startseite\" target=\"_blank\" rel=\"noreferrer noopener\">Nuvisan Pharma Holding<\/a>He will also take a seat on Visionhealth&#039;s advisory board in the future. <\/p>\n\n\n\n<p>The Munich-based company plans to use the raised capital to finance a second, larger study to provide decision-makers and physicians with even stronger scientific evidence for the evaluation and potential recommendation of Kata.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Basis for market access<\/h2>\n\n\n\n<p>The study, which involves approximately 120 patients suffering from chronic respiratory diseases such as asthma or COPD (chronic obstructive pulmonary disease), is designed as a randomized, controlled, multicenter trial lasting one year. It is intended to lay the foundation for Kata&#039;s market access in Germany, other EU countries, and possibly the US. At the same time, Visionhealth is working on strategic partnerships for international growth.<\/p>\n\n\n\n<p>Kata is a Class IIa medical device-certified app that provides targeted support for people with chronic lung diseases during inhalation therapy. Correct use of the inhalation device is crucial for therapeutic success. Incorrect inhalation results in less active ingredient reaching the lungs, which can lead to a more severe course of the disease over time. Repeated training of patients on the respective inhalation devices is often not possible in practice due to a lack of resources.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">\u201cThe incorrect inhalation of therapeutics can be a major error factor\u201d<\/h2>\n\n\n\n<p><strong>Dietrich Bruchmann<\/strong>, founder and CEO of the Nuvisan Pharma Holding Group, says: <\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>&quot;I&#039;m excited to see how Kata&#039;s potential will unfold as access improves for asthma and COPD patients. As the head of a CRO working in the respiratory care field, I was also fascinated by the use of the Kata Clinical app in clinical trials: Incorrect inhaled uptake of therapeutics can be a major error factor. Using the app to support each patient individually in using the inhaler correctly will not only improve the patient&#039;s daily outcomes but also the quality of clinical trial results, thus ensuring maximum benefit from the therapy.&quot;<\/p><\/blockquote>\n\n\n\n<p><a href=\"\/en\/82586\/women-in-tech-sabine-haeussermann-from-visionhealth\/\"><strong>Sabine H\u00e4u\u00dfermann<\/strong><\/a>, CEO and founder of Visionhealth, adds:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>\u201cWe are pleased to be able to combine the very positive results we received from our feasibility study with further data on the efficiency of Kata<sup> <\/sup>With over 2,400 users since its initial launch, an impressive 83.3 percent have told us they would continue to use the Kata app; a similar number of users would recommend the app to friends with respiratory conditions. It&#039;s truly gratifying to see how we can make a difference for patients and improve health outcomes. We greatly appreciate the continued support of our shareholders and our new investor, Dr. Buchmann of Nuvisan! <\/p><\/blockquote>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>The Munich-based medtech startup plans to use the fresh capital to finance a second study for its medical device Kata. <\/p>","protected":false},"author":24,"featured_media":46570,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5638,1],"tags":[243,3556],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Finanzierung: 3 Millionen Euro f\u00fcr Visionhealth - Munich Startup<\/title>\n<meta name=\"description\" content=\"Mit dem frischen Kapital will das M\u00fcnchner Medtech-Startup Visionhealth eine zweite Studie f\u00fcr sein Medizinprodukt Kata finanzieren.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/89485\/visionhealth-pre-series-a-financing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Finanzierung: 3 Millionen Euro f\u00fcr Visionhealth - Munich Startup\" \/>\n<meta property=\"og:description\" content=\"Mit dem frischen Kapital will das M\u00fcnchner Medtech-Startup Visionhealth eine zweite Studie f\u00fcr sein Medizinprodukt Kata finanzieren.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/89485\/visionhealth-pre-series-a-financing\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-03T10:30:00+00:00\" \/>\n<meta name=\"author\" content=\"Regina Bruckschl\u00f6gl\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Regina Bruckschl\u00f6gl\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/89485\/visionhealth-pre-series-a-finanzierung\/\",\"url\":\"https:\/\/cms.munich-startup.net\/89485\/visionhealth-pre-series-a-finanzierung\/\",\"name\":\"Finanzierung: 3 Millionen Euro f\u00fcr Visionhealth - Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/89485\/visionhealth-pre-series-a-finanzierung\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/89485\/visionhealth-pre-series-a-finanzierung\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/03\/VisionHealth_Team_Kern-e1553790317940.jpg\",\"datePublished\":\"2023-03-03T10:30:00+00:00\",\"author\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f\"},\"description\":\"Mit dem frischen Kapital will das M\u00fcnchner Medtech-Startup Visionhealth eine zweite Studie f\u00fcr sein Medizinprodukt Kata finanzieren.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/89485\/visionhealth-pre-series-a-finanzierung\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/89485\/visionhealth-pre-series-a-finanzierung\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/89485\/visionhealth-pre-series-a-finanzierung\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/03\/VisionHealth_Team_Kern-e1553790317940.jpg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/03\/VisionHealth_Team_Kern-e1553790317940.jpg\",\"width\":2000,\"height\":855,\"caption\":\"VisionHealth\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/89485\/visionhealth-pre-series-a-finanzierung\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"3 Millionen Euro f\u00fcr Visionhealth\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f\",\"name\":\"Regina Bruckschl\u00f6gl\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g\",\"caption\":\"Regina Bruckschl\u00f6gl\"},\"description\":\"Nach eigenen Startup-Erfahrungen blickt sie als Redakteurin von Munich Startup nun aus einer anderen Perspektive auf die M\u00fcnchner Startup-Szene \u2013 und entdeckt dabei jeden Tag, wie vielf\u00e4ltig das M\u00fcnchner \u00d6kosystem ist. Startup Stories, die erz\u00e4hlt werden wollen!\",\"sameAs\":[\"https:\/\/cms.munich-startup.net\"],\"url\":\"https:\/\/cms.munich-startup.net\/en\/author\/regina\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2019\/03\/VisionHealth_Team_Kern-e1553790317940.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2000\" \/>\n\t<meta property=\"og:image:height\" content=\"855\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Financing: 3 million euros for Visionhealth - Munich Startup","description":"With the fresh capital, the Munich-based medtech startup Visionhealth plans to finance a second study for its medical device Kata.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/89485\/visionhealth-pre-series-a-financing\/","og_locale":"en_US","og_type":"article","og_title":"Finanzierung: 3 Millionen Euro f\u00fcr Visionhealth - Munich Startup","og_description":"Mit dem frischen Kapital will das M\u00fcnchner Medtech-Startup Visionhealth eine zweite Studie f\u00fcr sein Medizinprodukt Kata finanzieren.","og_url":"https:\/\/cms.munich-startup.net\/en\/89485\/visionhealth-pre-series-a-financing\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_published_time":"2023-03-03T10:30:00+00:00","author":"Regina Bruckschl\u00f6gl","twitter_card":"summary_large_image","twitter_creator":"@munich_startup","twitter_site":"@munich_startup","twitter_misc":{"Written by":"Regina Bruckschl\u00f6gl","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/89485\/visionhealth-pre-series-a-finanzierung\/","url":"https:\/\/cms.munich-startup.net\/89485\/visionhealth-pre-series-a-finanzierung\/","name":"Financing: 3 million euros for Visionhealth - Munich Startup","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/89485\/visionhealth-pre-series-a-finanzierung\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/89485\/visionhealth-pre-series-a-finanzierung\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/03\/VisionHealth_Team_Kern-e1553790317940.jpg","datePublished":"2023-03-03T10:30:00+00:00","author":{"@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f"},"description":"With the fresh capital, the Munich-based medtech startup Visionhealth plans to finance a second study for its medical device Kata.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/89485\/visionhealth-pre-series-a-finanzierung\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/89485\/visionhealth-pre-series-a-finanzierung\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/89485\/visionhealth-pre-series-a-finanzierung\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/03\/VisionHealth_Team_Kern-e1553790317940.jpg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/03\/VisionHealth_Team_Kern-e1553790317940.jpg","width":2000,"height":855,"caption":"VisionHealth"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/89485\/visionhealth-pre-series-a-finanzierung\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"3 Millionen Euro f\u00fcr Visionhealth"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f","name":"Regina Bruckschl\u00f6gl","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g","caption":"Regina Bruckschl\u00f6gl"},"description":"After her own startup experiences, she now looks at the Munich startup scene from a different perspective as an editor at Munich Startup \u2013 and discovers every day how diverse the Munich ecosystem is. Startup stories that beg to be told!","sameAs":["https:\/\/cms.munich-startup.net"],"url":"https:\/\/cms.munich-startup.net\/en\/author\/regina\/"}]},"og_image":[{"width":2000,"height":855,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/03\/VisionHealth_Team_Kern-e1553790317940.jpg","type":"image\/jpeg"}]},"_showyear":"","_inactive":"","_show_financing":"","_hide_on_map":"","_edit_lock":"1677766728:26","_edit_last":"26","_yoast_wpseo_focuskw":"Visionhealth","_yoast_wpseo_metadesc":"Mit dem frischen Kapital will das M\u00fcnchner Medtech-Startup Visionhealth eine zweite Studie f\u00fcr sein Medizinprodukt Kata finanzieren.","_yoast_wpseo_linkdex":"71","_thumbnail_id":"46570","wbounce_status":"default","_yoast_wpseo_primary_category":"5638","_yoast_wpseo_focuskw_text_input":"","_yoast_wpseo_content_score":"30","ms_image_format":"contentwidth","_ms_image_format":"field_5cb8587572c8b","ms_dachzeile":"","_ms_dachzeile":"field_5cd9b7f365df5","ms_bump_post_date":"","_ms_bump_post_date":"field_5d1341edcf42a","guest_author_name":"","_guest_author_name":"field_5cee78a6016f9","guest_author_image":"","_guest_author_image":"field_5cee7914016fb","guest_author_description":"","_guest_author_description":"field_5cee78dd016fa","ms_post_image_caption":"","_ms_post_image_caption":"field_5f735b0735284","ms_post_image_credit":"","_ms_post_image_credit":"field_5f735b1435285","suppress_startupbox":"0","_suppress_startupbox":"field_60a64b0b6efc6","_yoast_wpseo_estimated-reading-time-minutes":"2","_wp_old_date":"","_yoast_wpseo_title":"Finanzierung: %%title%% %%page%% %%sep%% %%sitename%%","_yoast_wpseo_wordproof_timestamp":"","footnotes":"","easy_language_simplification_original_id":"","easy_language_source_language":"","easy_language_simplification_language":"","easy_language_api":"","easy_language_prevent_automatic_mode":"","_wp_old_slug":"","_wp_trash_meta_status":"","_wp_trash_meta_time":"","easy_language_simplification_state_changed_from":"","easy_language_de_EL_changed":"","ms_competition_deadline":"","_ms_competition_deadline":"","_wpbitly":"","enclosure":"","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","wbounce_template":"","wbounce_title":"","wbounce_text":"","wbounce_cta":"","wbounce_url":"","wbounce_override":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_oembed_7131efca3705e16bd9da2c41df237660":"","_oembed_time_7131efca3705e16bd9da2c41df237660":"","_pprredirect_type":"","_pprredirect_url":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":"","_newsletterglue":"","easy_language_text_language":"","_wp_desired_post_slug":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/89485"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=89485"}],"version-history":[{"count":5,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/89485\/revisions"}],"predecessor-version":[{"id":89505,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/89485\/revisions\/89505"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/46570"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=89485"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/categories?post=89485"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=89485"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}